BURLINGTON, ON, Nov. 8, 2012 /CNW/ - EKO INTERNATIONAL INC. (the "Company") - (EKNL- Pinksheets) is pleased to announce that marketing efforts initiated prior to the Canadian Federation of Podiatric Medicine Conference held in London, Ontario on October 26th and 27th, 2012, have resulted in the preparation of clinical facilities in Chicago Illinois and Sault Ste. Marie, Ontario, Canada by health professionals to administer tests and to provide treatments for diabetic patients suffering from peripheral neuropathy.
NeuroVasc Clinical Inc. (NCI) is supplying the testing and treatment equipment to these facilities.
Consultations continue with several other groups preparing to provide testing and treatment facilities in a number of larger urban areas in Canada and the USA. While the sale of testing and treatment equipment is the prime objective of NCI, the supplying of single use disposable testing strips and treatment pads is expected to provide a significant growing and continual revenue stream to NCI.
This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by EKO International ("The Company") are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company's expectations include, but are not limited to, those factors that are disclosed under the heading "Risk Factors" and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities.
SOURCE: EKO INTERNATIONAL CORP.
For further information:
To contact the company by e-mail, please use email@example.com